As a first step in this direction, here we expressed a chimeric granzyme B fusion protein in human NK cells that carries the peptide ligand TGFα for targeting to EGFR, and evaluated its effect on natural cytotoxicity and its cell killing activity towards EGFR-expressing tumor cells. This evidence concerns the gene GZMB and neoplasm.